DANIELLE CARA: Open Payments
NPI 1093543159 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,857 in 83 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $360 · 2025 $1,857
Food & beverage: $1,857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $272 |
| ABBVIE INC. | 14 | $249 |
| PFIZER INC. | 6 | $234 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $191 |
| Novo Nordisk Inc | 8 | $169 |
| Lilly USA, LLC | 8 | $157 |
| Abbott Laboratories | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
Products named: Kerendia, NURTEC ODT, AIRSUPRA, VRAYLAR, MOUNJARO, FREESTYLE LIBRE 3, QULIPTA, XIFAXAN.
Industry payments across PA — which companies pay providers there.
